+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy



Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy



Hospital Practice 27(Suppl. 2): 14-25



Combination antiretroviral therapy is an important development in the management of HIV infection. AZT with ddC is the first such combination to be approved for clinical use. Several issues remain, however, including the precise clinical benefit and toxicity of combination therapy, its effect on drug resistance, and the development of ever more effective therapeutic strategies.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041848597

Download citation: RISBibTeXText

PMID: 1324254


Related references

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects. Hospital Practice 27(Suppl. 2): 26-36, 1992

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy. Hospital Practice 27(Suppl. 2): 5, 1992

Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues. Gene Therapy 6(2): 162-170, 1999

Human immunodeficiency virus (HIV) resistance to nucleoside analogues: A rationale for nucleoside combination therapy?. Pathologie Biologie 41(8 Suppl.): 788-793, 1993

Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction. Hospital Practice 27(Suppl. 2): 3-4, 1992

Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus. Biochemical Pharmacology 51(6): 731-736, 1996

Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. Biochemical Pharmacology 36(22): 3815-3822, 1987

Raltegravir plus two nucleoside analogues as combination antiretroviral therapy in HIV-infected patients who require cancer chemotherapy. Antiviral Therapy 20(7): 773-777, 2015

Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy. Journal of Antimicrobial ChemoTherapy 66(10): 2372-2378, 2011

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals. Antiviral Therapy 8(6): 603-609, 2003

Combination therapy of HIV infection with protease inhibitors and nucleoside analogues: A clinical experience. Giornale Italiano di Malattie Infettive 4(2): 92-98, March-April, 1998

Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents. Aids 12(Suppl. 3): S17-S22, 1998

Nucleoside analogues 9. seco nucleoside analogues of some 5 fluorouracil nitrosourea molecular combinations having uracil as base synthesis and anti tumor activity. Anti Cancer Drug Design 4(3): 191-208, 1989

Conformationally locked nucleoside analogues. Synthesis of dideoxycarbocyclic nucleoside analogues structurally related to neplanocin C. Journal of Medicinal Chemistry 37(20): 3389-3399, 1994

Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study. HIV Clinical Trials 16(1): 43-48, 2015